158例白血病分型分析

目的通过回顾性调查,探讨北海市白血病发病情况. 方法按FAB白血病诊断与分型标准.结果从18年在该院就诊和住院的患者6306435人次中,初发并确诊的各类白血病158例,发病率2.5/105与1988年全国调查的各类白血病发病率2.62/105相近;各类白血病的构成比、性别、年龄以及各类白血病亚型分布等结果分析与全国、上海市等区域的调查分析结果也很近似.结论该文样本量很大,可基本反映北海市白血病发病率的概况.     

中药安迪对HL-60细胞分化的诱导作用

目的　探讨安迪粉针剂 (Andi)对 HL- 60细胞分化的诱导作用 .方法　采用人早幼粒白血病细胞株 (HL - 60 )为靶细胞 ,分为不加任何药物的对照组 (C组 )、安迪粉针剂 (Andi)组、阳性对照药维甲酸 (RA)组和苦参 (KS)组 ,进行体外培养和诱导分化 ,观测细胞生长曲线、细胞形态、硝基蓝四氮唑(NBT)还原和吞噬能力等指标 .结果　 2 mg· L-1 Andi可显著地抑制 HL - 60细胞增殖 ,使原始细胞分化为中幼以下的成熟细胞 ,分化后的细胞具有 NBT还原能力和吞噬功能 ;Andi为 68.0 % ,RA为 61 .5% ,KS为 59.0 % ,C组还原能力仅6.0 % (P<0 .0 1 vs C) .其形态的改变和吞噬能力与阳性对照药维甲酸 (RA)和苦参 (KS)相似 ,分别为 52 .0 % ,45.5%和56.5% (P>0 .0 5) ;均明显高于空白对照组 .C组吞噬功能仅7.5% (P <0 .0 1 vs C)其 NBT还原能力与 KS相当 (P >0 .0 5) .结论　 Andi对 HL - 60细胞具有显著的诱导分化作用     

慢性髓性白血病细胞来源的树突状细胞大容量诱导及其功能的实验研究

目的　探索大容量诱导慢性髓性白血病 (CML)细胞来源的树突状细胞 (DCs)的适宜方法 ;研究CML DCs刺激自体T淋巴细胞增殖并分泌γ 干扰素 (IFN γ)的能力。方法　用CS 30 0 0 plus血细胞分离机采集初诊CML病人的外周血单个核细胞 (PBMNCs) ;单采的CML PBMNCS转入组织培养袋 ,加入重组人粒 巨细胞集落刺激因子 (rhGM CSF)和重组人白介素 4 (rhIL 4 ) ,培养诱导 7d ;在诱导前后 ,用流式细胞仪分别检测细胞表面HLA DR、CD1a、CD80和CD86的表达水平 ;用3 H TdR掺入法检测CML DCs和CML PBMNCs刺激自体和异体T细胞增殖的能力 ;用ELISA法检测在自体混合淋巴细胞培养 (MLR)时T细胞分泌的IFN γ浓度。结果　用血细胞分离机收集的CML PBMNCs ,在组织培养袋内经细胞因子培养诱导 ,HLA DR、CD1a、CD80、CD86的表达均有明显上调 ,细胞形态也表现典型的DC特征 ;CML DCs能显著刺激自体和异体T细胞增殖 ,而CML PBM NCs仅能刺激异体T细胞的增殖 ,刺激自体T细胞增殖的能力很弱 ;刺激自体T细胞增殖时分泌的IFN γ浓度 ,CML DCs组为 (877± 2 14 )pg/mL ;CML BPMNCs组仅为 (14± 1.7) pg/mL。 结论　单采的CML PBMNCs转入组织培养袋 ,加入rhGM CSF和rhIL 4 ,可收获大容量的CML DCs;CML DCs在体外具有显著刺激自体T细胞增殖     

白血病肺部并发症的影像学分析

目的　分析白血病肺部并发症影像学特点 ,提高诊断白血病肺部并发症的水平。方法　分析 2 0 0例白血病肺部并发症的影像学特点。结果　并发症的致病因素 :单一细菌感染占 3 3 .5% (67例 ) ,细菌混合感染占 3 5% (70例 ) ,真菌感染占 3 .5% (7例 ) ,真菌细菌混合感染占 5% (10例 ) ,致病菌不明占 2 3 % (46例 )。影像学表现 :肺纹理改变 84例 (42 % ) ,肺实质病变 116例 (58% ) ,胸膜改变 2 9例 (14 .5% ) ,胸腔积液 19例 (9.5% ) ,肺门或纵隔改变 40例 (2 0 % )。结论　白血病肺部并发症以感染为多见 ,诊断应结合临床和实验室检查。此外治疗后复查对照亦有助于鉴别     

Differential Expression of Subspecies of Polyomavirus and Murine Leukemia Virus Enhancer Core Binding Protein, PEBP2, in Various Hematopoietic Cells

The core sequence of the enhancer of murine leukemia virus (MuLV) long terminal repeat is highly conserved in a large number of MuLV strains and appears to play an essential role when SL3-3 or Moloney strains induce T cell lymphoma in mice. We found by using the electrophoretic mobility shift assay that a polyomavirus enhancer core-binding protein, PEBP2, bound to this core motif of MuLV. We also noted that PEBP2 in several hematopoietic cell lines derived from B lymphocyte, macrophage and myelocyte lineages migrated significantly faster than the authentic PEBP2 detected in NIH3T3 (ibroblasts. Interestingly, PEBP2 detected in the cell lines of T lymphocyte lineage appeared to contain both types, which were indistinguishable in electrophoretic mobility from those of NIH3T3 and of B lymphocyte, macrophage and myelocyte lineages. The treatment of the nuclear extract containing PEBP2 with phosphatase generated PEBP3, which is a subcomponent of PEBP2 and retained the same DNA-binding specificity as PEBP2. The altered mobility of hematopoietic cell-derived or T lymphocyte-derived PEBP2 was found to be due to the alteration of the mobility of PEBP3. Based on the distinct mobility of PEBP2/3 of T lymphocytes from those of other hematopoietic cells, we discuss the implication of PEBP2 in MuLV-induced T cell leukemia and T cell-specific gene expression.     

白血病患者血浆和外周血白细胞内维生素变化

检测４５例正常人和４４例不同病期白血病血浆和外周血白细胞内维生素Ａ、Ｅ、Ｃ、Ｂ１２和β－胡罗卜素、叶酸浓度。结果表明，初治白血病患者血浆维生素Ａ、β－胡罗卜素降低（Ｐ＜０．０１），未缓期解者血浆β－胡罗卜素和叶酸低于正常（Ｐ＜０．０１和Ｐ＜０．０５）。在初治和未缓解期患者的外周血白细胞内，维生素Ｅ、Ｃ、Ｂ１２和β－胡罗卜素均显著降低（Ｐ＜０．０１～０．００１）。而且，外周血白细胞内维生素代谢异常比血浆更为显著。提示维生素含量变化对于解释病因，预测疗效及估计预后有一定的价值。     

Outcome of a multicenter treatment program including autologous or allogeneic bone marrow transplantation for de novo acute myeloid leukemia

Abstract: The results of an intensive treatment program for patients 16–60 yr of age with de novo acute myeloid leukemia are presented. The patients were given conventional induction treatment with daunorubicin and cytarabine. Patients not entering complete remission (CR) after 1 course of daunorubicin/cytarabine were given 1 course of amsacrine/etoposide/cytarabine. Those entering complete remission received 3 consolidation courses using mitoxantrone, etoposide, amsacrine and cytarabine. One hundred and eighteen patients were enrolled. Complete remission was attained after 1–2 courses in 90 patients (76%). Another 6 patients reached CR after 3–4 induction courses for a total CR rate of 81%. If feasible, patients were offered either allogeneic or unpurged autologous bone marrow transplantation. Twenty-four patients underwent allogeneic bone marrow transplantation; 15 in first remission, 8 in second remission, 1 in early relapse. Thirty patients below 56 yr of age underwent autologous bone marrow transplantation in first remission. The overall probability of survival at 4 yr was 34%, and for patients below 40 yr of age 50%. Leukemia-free survival was 35% for the whole cohort of patients; 52% for patients below 40 yr of age. Patients undergoing allogeneic or autologous bone marrow transplantation in first remission had an overall survival of 86% and 47%, respectively, while the probability of leukemia-free survival in these groups was 87% vs. 40% at 4 yr. The CR rate and long-term results of this intensive treatment program compare favorably with other recent studies using intensive consolidation with allogeneic or autologous bone marrow transplantation or high dose cytarabine.     

TPA诱导的血小板聚集的研究

应用不同浓度ＴＰＡ诱发血小板聚集，观察２０名正常人血小板的聚集率。结果显示：ＴＰＡ从５ｎｇ／ｍｌ到１０ｎｇ／ｍｌ之间，随着浓度的增加，血小板聚集率逐渐增加，最佳浓度为１０ｎｇ／ｍｌ。当ＴＰＡ浓度〉１０ｍｇ／ｍｌ时，继续增加ＴＰＡ浓度，血小板聚集率将不再升高，且于２０ｍｇ／ｍｌ时出现明显的解聚现象。     

Leukemia,lymphoma, and multiple myeloma following selected medical conditions

The role of selected prior medical conditions in the etiology of hematopoietic malignancies was examined in a case-control study of members of two regional branches of the Kaiser Permanente Medical Care Program (USA). Past history of chronic infectious, autoimmune, allergic, and musculoskeletal disorders was abstracted from medical records for leukemia (n = 299), non-Hodgkin's lymphoma (NHL, n = 100), and multiple myeloma (n = 175) cases and matched controls (n = 787). Little difference was found between cases and controls for most of the chronic conditions evaluated, including sinusitis, carbuncles, urinary tract infections, pelvic infections, herpes zoster, asthma, rheumatoid arthritis, psoriasis, bursitis, and gout. Only three statistically significant elevated risks were found, i.e., with combined disc disease myeloma among patients with prior eczema and disk and other musculoskeletal conditions, and NHL following tuberculosis. Only two of these associations showed consistent patterns by sex and geographic region (myeloma with eczema and with musculoskeletal conditions). While prior history of eczema and musculoskeletal conditions may slightly increase risk of myeloma, this study provided little if any support for an association of chronic infectious, autoimmune, allergic, and musculoskeletal conditions with subsequent occurrence of the leukemias or NHL. Additionally, these data did not support a role for chronic antigenic stimulation, as defined in previous epidemiologic studies, in the etiology of hematopoietic malignancies.Ms Doody and Drs Linet, Pottern, Boice, and Fraumeni are with the Epidemiology and Biostatistics Program, National Cancer Institute. Dr Glass is with the Kaiser Permanente Medical Care Program, Northwest Region, Portland, Oregon, USA. Dr Friedman is with the Kaiser Permanente Medical Care Program, Northern California Region, Oakland, California, USA. Address correspondence to Ms Doody, Radiation Epidemiology Branch, National Cancer Institute, Executive Plaza North, Room 408, Bethesda, MD 20892, USA. This research was supported in part by National Cancer Institute contracts NO1-CP-01047, NO1-CP-01054, NO1-CP-11009, NO1-CP-11037, NO1-CP-31035, and NO1-CP-61006.     

硒和维生素C对白血病细胞增殖及细胞毒性的研究

目的本文主要研究硒和维生素Ｃ影响髓系与非髓系白血病细胞增殖及其细胞毒性的异同。方法体外培养髓系白血病细胞株ＨＬ６０及非髓系细胞株Ｋ５６２，培养时分别设Ｓｅ（５μｍ、８μｍ、１１μｍ）及ＶｉｔＣ（５μｍ、１０μｍ、１００μｍ）实验组及对照组，培养２４ｈ、４８ｈ、７２ｈ后分别取样，利用台盼蓝拒染法进行细胞计数，绘制细胞生长曲线，并通过噻唑蓝比色分析法研究Ｓｅ及ＶｉｔＣ对ＨＬ６０、Ｋ５６２细胞毒性。结果细胞生长曲线显示：Ｓｅ（５～１１μｍ）及ＶｉｔＣ（５～１０μｍ）对ＨＬ６０、Ｋ５６２细胞增殖均有抑制作用。ＭＴＴ结果显示：Ｓｅ（５～１５μｍ）对两种细胞均有细胞毒性。ＶｉｔＣ（５～１０μｍ）对ＨＬ６０具有细胞毒性，而ＶｉｔＣ（５～１００μｍ）对于Ｋ５６２，短时间内毒性作用较明显，随作用时间延长而减弱。结论本实验结果提示：Ｓｅ及ＶｉｔＣ对髓系和非髓系白血病细胞增殖均有抑制作用，但ＶｉｔＣ对于ＨＬ６０和Ｋ５６２作用机制是不同的。这为白血病的化学预防和临床辅助治疗提供一定的理论依据。